PE20001366A1 - Metodo para la preparacion de eteres de arilo - Google Patents

Metodo para la preparacion de eteres de arilo

Info

Publication number
PE20001366A1
PE20001366A1 PE1999001328A PE00132899A PE20001366A1 PE 20001366 A1 PE20001366 A1 PE 20001366A1 PE 1999001328 A PE1999001328 A PE 1999001328A PE 00132899 A PE00132899 A PE 00132899A PE 20001366 A1 PE20001366 A1 PE 20001366A1
Authority
PE
Peru
Prior art keywords
reaction
compound
epoxide
alcohol
alkyl
Prior art date
Application number
PE1999001328A
Other languages
English (en)
Spanish (es)
Inventor
Kevin E Henegar
Sarah Elizabeth Mancini
Keith Douglas Maisto
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20001366A1 publication Critical patent/PE20001366A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/04—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reaction of ammonia or amines with olefin oxides or halohydrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/63—Esters of sulfonic acids
    • C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
    • C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
    • C07C309/66—Methanesulfonates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D301/00—Preparation of oxiranes
    • C07D301/02—Synthesis of the oxirane ring
    • C07D301/03—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds
    • C07D301/14—Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds with organic peracids, or salts, anhydrides or esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/14—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by free hydroxyl radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
PE1999001328A 1998-12-29 1999-12-28 Metodo para la preparacion de eteres de arilo PE20001366A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11409298P 1998-12-29 1998-12-29

Publications (1)

Publication Number Publication Date
PE20001366A1 true PE20001366A1 (es) 2000-11-19

Family

ID=22353332

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999001328A PE20001366A1 (es) 1998-12-29 1999-12-28 Metodo para la preparacion de eteres de arilo

Country Status (24)

Country Link
US (1) US6376711B1 (enExample)
EP (2) EP1140788B1 (enExample)
JP (1) JP2002533430A (enExample)
KR (2) KR100616386B1 (enExample)
CN (3) CN100340552C (enExample)
AT (2) ATE260238T1 (enExample)
AU (1) AU764492B2 (enExample)
BR (1) BR9916615A (enExample)
CA (1) CA2349619A1 (enExample)
CO (1) CO5140125A1 (enExample)
DE (2) DE69940833D1 (enExample)
DK (1) DK1140788T3 (enExample)
ES (1) ES2214060T3 (enExample)
HK (1) HK1041688B (enExample)
HU (1) HUP0202144A3 (enExample)
IL (2) IL161840A0 (enExample)
NZ (1) NZ511452A (enExample)
PE (1) PE20001366A1 (enExample)
PT (1) PT1140788E (enExample)
SI (1) SI1140788T1 (enExample)
TR (1) TR200101885T2 (enExample)
TW (1) TWI238155B (enExample)
WO (1) WO2000039072A1 (enExample)
ZA (1) ZA200103532B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796069B3 (fr) 1999-07-09 2001-08-24 Sanofi Synthelabo Nouveaux procedes de preparation de derives de 2-(2- arylmorpholin-2-yl)ethanol substitues, enantiomeriquement purs, et composes intermediaires utiles dans ces procedes
AR030284A1 (es) 2000-06-08 2003-08-20 Merck & Co Inc Proceso para la sintesis de (2r, 2-alfa-r,3a) -2-[1-(3,5-bis(trifluorometil) fenil) etoxi]-3-(4-fluorofenil)-1,4-oxazina; dicho compuesto y sus formas polimorficas
JP2007523153A (ja) * 2004-02-20 2007-08-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー アリールエーテルの製造方法
WO2005082869A1 (en) * 2004-02-20 2005-09-09 Pharmacia & Upjohn Company Llc Method for the preparation of aryl ethers
WO2005095435A1 (ja) * 2004-03-31 2005-10-13 Kuraray Co., Ltd. プレグナン誘導体の製造方法
AP2006003771A0 (en) 2004-04-30 2006-10-31 Warner Lambert Co Substituted morpholine compounds for the treatmentof central nervous system disorders
GB0409744D0 (en) * 2004-04-30 2004-06-09 Pfizer Ltd Novel compounds
GEP20125425B (en) 2006-10-18 2012-03-26 Pfizer Prod Inc Biaryl ether urea compounds
US20100069389A1 (en) * 2008-09-06 2010-03-18 Bionevia Pharmaceuticals, Inc. Novel forms of reboxetine
CN103804316A (zh) * 2012-11-13 2014-05-21 天津药物研究院 一种(2RS,3RS)-6-[a-(2-乙氧基苯氧基)苄基]吗啉-3-酮(Ⅰ)的制备方法
CN104557936A (zh) * 2015-01-15 2015-04-29 河南科技学院 一种新型手性非环嘌呤核苷类似物的合成方法
WO2019245975A1 (en) 2018-06-17 2019-12-26 Axsome Therapeutics, Inc. Compositions for delivery of reboxetine
US11020402B2 (en) 2018-10-15 2021-06-01 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US20200147093A1 (en) 2018-10-15 2020-05-14 Axsome Therapeutics, Inc. Use of esreboxetine to treat nervous system disorders such as fibromyalgia
US12616702B2 (en) 2019-12-03 2026-05-05 Axsome Therapeutics, Inc. Use of reboxetine to treat narcolepsy
US12565478B1 (en) 2025-01-21 2026-03-03 Axsome Therapeutics, Inc. (S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)-4-nitrosomorpholine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2785185A (en) * 1952-08-07 1957-03-12 Union Carbide & Carbon Corp Process for making oxirane compounds from olefins and aldehyde monoperacylates
GB1053972A (enExample) * 1962-08-30 1967-01-04
IL56369A (en) * 1978-01-20 1984-05-31 Erba Farmitalia Alpha-phenoxybenzyl propanolamine derivatives,their preparation and pharmaceutical compositions comprising them
GB8419683D0 (en) 1984-08-02 1984-09-05 Erba Farmitalia 3-substituted derivatives of 1-amino-2-hydroxy-propane

Also Published As

Publication number Publication date
HUP0202144A2 (hu) 2002-11-28
DE69915110T2 (de) 2004-08-26
HK1041688A1 (en) 2002-07-19
CN1532194A (zh) 2004-09-29
HK1078572A1 (zh) 2006-03-17
US6376711B1 (en) 2002-04-23
JP2002533430A (ja) 2002-10-08
ATE430144T1 (de) 2009-05-15
NZ511452A (en) 2002-11-26
CN1249038C (zh) 2006-04-05
KR20010099999A (ko) 2001-11-09
EP1140788B1 (en) 2004-02-25
CN100340552C (zh) 2007-10-03
TWI238155B (en) 2005-08-21
KR100616029B1 (ko) 2006-08-28
KR100616386B1 (ko) 2006-08-28
HK1066004A1 (en) 2005-03-11
BR9916615A (pt) 2001-10-23
HK1041688B (zh) 2007-12-07
ZA200103532B (en) 2002-08-02
EP1308443A2 (en) 2003-05-07
DE69940833D1 (de) 2009-06-10
PT1140788E (pt) 2004-07-30
IL144012A (en) 2005-11-20
ATE260238T1 (de) 2004-03-15
KR20060090310A (ko) 2006-08-10
SI1140788T1 (en) 2004-08-31
EP1140788A1 (en) 2001-10-10
CN1332719A (zh) 2002-01-23
WO2000039072A1 (en) 2000-07-06
CA2349619A1 (en) 2000-07-06
IL161840A0 (en) 2005-11-20
CN1308332C (zh) 2007-04-04
HUP0202144A3 (en) 2003-10-28
CN1636988A (zh) 2005-07-13
IL144012A0 (en) 2002-04-21
EP1308443A3 (en) 2003-10-01
TR200101885T2 (tr) 2002-01-21
DK1140788T3 (da) 2004-06-07
DE69915110D1 (de) 2004-04-01
ES2214060T3 (es) 2004-09-01
EP1308443B1 (en) 2009-04-29
AU2381900A (en) 2000-07-31
CO5140125A1 (es) 2002-03-22
AU764492B2 (en) 2003-08-21

Similar Documents

Publication Publication Date Title
Kazemi et al. Chemoselective and scalable preparation of alkyl tosylates under solvent-free conditions
US5780650A (en) Process for preparation of 1,4-benzodioxane derivative
GT199900216A (es) Polimorfos de acido 2-(3-ciano-4-isobutiloxifenil)-4-metil-5-tiazol carboxilico y metodo de produccion de los mismos.
ES2033423T3 (es) Procedimientos para preparar derivados de 2-fenilpurinona.
AR003472A1 (es) Un procedimiento para preparar un alcohol terciario, un compuesto derivado de alfa-halo-alquil pirimidina y un compuesto intermediario para preparar 6-(1-bromoetil)-4-cloro-5-fluoropirimidina
KR940007038A (ko) 밀베마이신의 13-에테르 유도체의 제조방법 및 그의 중간체
PE20001562A1 (es) Derivados de benzamida como inhibidores de la produccion hepatica de la apo proteina b-100
SE8106125L (sv) 4,5-polymetylen-4-isotiazolin-3-oner, sett for framstellning derav och anvendning derav som baktericida och fungicida medel
DK0547910T3 (da) Fremgangsmåde til fremstilling af 2-chlor-2-deoxyadenosin
PE20010962A1 (es) Derivados de heterociclo-alquilsulfonil-pirazol como agentes anti-inflamatorios/analgesicos
MX162343A (es) Procedimiento para la preparacion de derivados de piridobenzotiazina
ES2021941A6 (es) Procedimiento para la preparacion de nuevos derivados de pirimidinil-piperacinil-alquil azoles.
AR048875A1 (es) Un proceso para preparar montelukast y compuestos intermedios para el mismo
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
KR890012982A (ko) 치환된 1,2,4-트리아진디온, 이의 제조방법 및 용도
NZ511452A (en) Method for the preparation of aryl ethers such as reboxetine
DK518487A (da) 7-(meta-substitueret phenylglycin)-1-carba-1-dethiacephalosporiner og fremgangsmaade til fremstilling heraf
KR830007505A (ko) 페닐알킬아민의 제조방법
KR880003889A (ko) 나프탈렌 및 인단 유도체,이들 화합물을 함유하는 약제학적 조성물 및 그들의 제조 방법
ES8402557A1 (es) Esteres fenolicos.
AR006876A1 (es) Procedimiento e intermedios para preparar el compuesto {2-(2-[1,2,4]- triazol-3-ilmetil)-1,2,3,4-tetrahidroisoquinolin-6-il} amida del acido 4'-trifluorometilbifenil-2-carboxilico
DK458283D0 (da) Fremgangsmade til fremstilling af phenylindenderivater eller syreadditionssalte deraf
US5965753A (en) Process for preparation of glycidyl sulfonate derivative
ES8304976A1 (es) "procedimiento para la preparacion de derivados triptaminicos sustituidos de tieniloxipropanolaminas, racemicos y opticamente activos".
US5834507A (en) Antineoplastic cyclolignan derivatives

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed